Package Leaflets (PL) for Human medicinal products

The package leaflet (PL) provides users with information about the medicinal product and its correct use. The package leaflets contain instructions in both Finnish and Swedish.

The package leaflets can be searched from alphabetical list, with the name, marketing authorisation number and the Anatomical Therapeutic Chemical, i.e. ATC Code of the Summary of Product Characteristics, SPC.

The package leaflets processed as part of the EU centralised marketing authorisation procedure are published by the European Medicines Agency, EMA. Fimea's service contains links to the documents on medicinal products (EPAR PI) on the EMA website. Drugs belonging to the centralised authorisation procedure can be searched in Fimea's service by using an alphabetical list or by entering the product name or ATC code.

The material being published is not necessarily complete or up-to-date due to the technical quality of files submitted to the Finnish Medicines Agency Fimea or earlier to the National Agency for Medicines and the delays in delivery. For this reason, Fimea cannot guarantee that the document on the Internet fully complies with the summary of product characteristics and package leaflet officially approved by a desicion for a marketing authorisation. Only the hard copies of the SPCs and the PLs, which are in accordance with the marketing authorisation, are conclusive.

Product Information Leaflets 1 - 30 of 231
1  2  3  4  5  6  7  8  |  Next 30   >
SPC	Status for supply	Name of the medicinal product
		European Medicines Agency's website: Naglazyme - EMA: EPAR PI Finnish Swedish
SPC	Resepti	Naldix 50 mg tabletti, kalvopäällysteinen PL 2023-02-28
SPC	Resepti	Naloxon B. Braun 0.4 mg-ml injektio-infuusioneste, liuos PL 2018-03-14
SPC	Resepti	Naloxone Accord 0,4 mg-ml injektio-infuusioneste, liuos, esitäytetty ruisku PL 2024-07-09
SPC	Resepti	Naltrexon Accord 50 mg tabletti, kalvopäällysteinen PL 2024-06-14
SPC	Resepti	Naltrexon Vitaflo 50 mg tabletti, kalvopäällysteinen PL 2022-04-26
SPC	Resepti	Naltrexone Poa Pharma 50 mg tabletti, kalvopäällysteinen PL 2023-02-28
		European Medicines Agency's website: Namuscla - EMA: EPAR PI Finnish Swedish
SPC	Resepti	Nanogam 100 mg-ml infuusioneste, liuos PL 2024-06-21
SPC	Resepti	Nanogam 50 mg-ml infuusioneste, liuos PL 2021-10-14
SPC	Resepti	Naprometin 500 mg tabletti PL 2024-10-01
SPC	Resepti	Napromex 500 mg tabletti, kalvopäällysteinen PL 2024-07-05
SPC	Resepti	Naproxen Accord 250 mg, 500 mg tabletti PL 2024-10-17
SPC	Resepti	Naproxen Krka 550 mg tabletti, kalvopäällysteinen PL 2024-08-28
SPC	Resepti	Naproxen Orion 250 mg, 500 mg tabletti PL 2024-07-18
SPC	Resepti	Naramig 2.5 mg tabletti, kalvopäällysteinen PL 2023-11-30
SPC	Resepti	Naratriptan Orifarm 2,5 mg kalvopäällysteinen tabletti PIL 2018-10-03.docx
SPC	Itsehoito	Nasacort 55 mikrog-annos nenäsumute, suspensio OTC PL 2023-07-15
SPC	Resepti	Nasacort 55 mikrog-annos nenäsumute, suspensio Rx PL 2023-07-15
SPC	Itsehoito	Nasment 1 mg-ml nenäsumute, liuos PL 2021-08-03
SPC	Itsehoito	Naso-Ratiopharm 0.5 mg/ml, 1 mg/ml nenäsumute, liuos PL 2020-02-03
SPC	Itsehoito	Nasofan 50 mikrog-annos nenäsumute, suspensio OTC PL 2022-09-29
SPC	Resepti	Nasofan 50 mikrog-annos nenäsumute, suspensio Rx PL 2022-09-29
SPC	Itsehoito	Nasolin 0.5 mg-ml, 1 mg-ml nenäsumute, liuos PL 2024-03-05
SPC	Itsehoito	Nasolin 0.5 mg-ml, 1 mg-ml nenäsumute, liuos PL 2024-03-05
SPC	Resepti	Nasonex 50 mikrog-annos nenäsumute, suspensio PL 2022-11-14
		European Medicines Agency's website: Natpar - EMA: EPAR PI Finnish Swedish
SPC	Itsehoito	Natr. Chlorid. 9 mg-ml nenätipat, liuos PL 2020-12-07
SPC	Resepti	Natrilix 2.5 mg tabletti, kalvopäällysteinen PL 2021-10-22
SPC	Resepti	Natrilix Retard 1.5 mg depottabletti PL 2021-10-21
1  2  3  4  5  6  7  8  |  Next 30   >